Reuters
•80% Informative
New diabetes and weight-loss drugs may benefit patients undergoing hip replacement.
Preliminary data released on Monday at a large meeting of orthopedic surgeons.
Semaglutide is associated with 44% lower odds of developing an infection of the newly implanted joint.
Those taking Ozempic had 32% lower risk of needing to be readmitted to the hospital.
VR Score
91
Informative language
98
Neutral language
64
Article tone
formal
Language
English
Language complexity
67
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links